H.C. Wainwright Reiterates Buy Rating on Zymeworks (ZYME)
Tweet Send to a Friend
H.C. Wainwright analyst Andrew Berens reiterated a Buy rating and $26.00 price target on Zymeworks (NASDAQ: ZYME).The analyst commented: 'Over ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
